Product Information
RIVASTIGMINE 4.5 MG CAPSULE is a generic product labeled by Chartwell RX LLC, priced at $0.2058 per EA under NDC 62135090260. Its NADAC has been published 159 times since Jun 14, 2023.
Strength
4.5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135090260
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207797On Market Since
9/28/2017
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 4.5 MG CAPSULE has been published 159 times since Jun 14, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2058 per EA |
|---|---|
| All-time high | $0.2702 (Feb 14, 2024) |
| All-time low | $0.1780 (Jul 17, 2024) |
| 52-week high | $0.2215 |
| 52-week low | $0.1871 |
| Median price | $0.2042 |
| Average price | $0.2107 |
| Largest weekly change | -23.0% (Feb 21, 2024) |
| Weeks tracked | 159 |
| Tracking since | Jun 14, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 4.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 4.5 MG CAPSULE, manufactured by Chartwell RX LLC, is $0.2058 per EA (NDC 62135090260), effective Jun 24, 2026.
How has the price of RIVASTIGMINE 4.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 4.5 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 159 weekly CMS publications since Jun 14, 2023.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 4.5 MG CAPSULE?
Since Jun 14, 2023, the NADAC for RIVASTIGMINE 4.5 MG CAPSULE has ranged from a low of $0.1780 (Jul 17, 2024) to a high of $0.2702 (Feb 14, 2024), with a median of $0.2042 per EA.
Are there cheaper alternatives to RIVASTIGMINE 4.5 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RIVASTIGMINE 4.5 MG CAPSULE, is $0.1992 per EA — about 3% below RIVASTIGMINE 4.5 MG CAPSULE.
Who manufactures RIVASTIGMINE 4.5 MG CAPSULE?
RIVASTIGMINE 4.5 MG CAPSULE (NDC 62135090260) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification